Venkat Ramanan - 16 Oct 2023 Form 4 Insider Report for Turnstone Biologics Corp. (TSBX)

Role
Chief Financial Officer
Signature
/s/ P. Joseph Campisi, Jr., Attorney-in-Fact
Issuer symbol
TSBX
Transactions as of
16 Oct 2023
Transactions value $
$0
Form type
4
Filing time
17 Oct 2023, 18:42:44 UTC
Previous filing
20 Jul 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TSBX Employee Stock Option (Right to Buy) Award $0 +46,606 $0 46,606 16 Oct 2023 Common Stock 46,606 $2.61 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One fourth (1/4th) of the shares subject to the option award shall vest on October 12, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.